MI MEDICAL INNOVATION : revenue, balance sheet and financial ratios

MI MEDICAL INNOVATION is a French company founded 26 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in CHANAC (48230), this company of category PME shows in 2018 a revenue of 1.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - MI MEDICAL INNOVATION (SIREN 423697762)
Indicator 2019 2018 2017 2016
Revenue N/C 1 033 992 € 996 386 € 881 520 €
Net income -9 989 € -11 083 € 96 350 € 61 412 €
EBITDA N/C 29 784 € 117 075 € 69 985 €
Net margin N/C -1.1% 9.7% 7.0%

Revenue and income statement

In 2019, MI MEDICAL INNOVATION records a net loss of 10 k€. This deficit will reduce equity on the balance sheet.

Net income (2019) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-9 989 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 30%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2019) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

29.799%

Financial autonomy (2019) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

56.137%

Asset age ratio (2019) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

58.7%

Solvency indicators evolution
MI MEDICAL INNOVATION

Sector positioning

Debt ratio
29.8 2019
2017
2018
2019
Q1: 2.28
Med: 19.82
Q3: 59.57
Average

In 2019, the debt ratio of MI MEDICAL INNOVATION (29.80) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
56.14% 2019
2017
2018
2019
Q1: 20.57%
Med: 46.58%
Q3: 66.44%
Good -13 pts over 3 years

In 2019, the financial autonomy of MI MEDICAL INNOVATION (56.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
-24.64 years 2018
2017
2018
Q1: 0.0 years
Med: 0.26 years
Q3: 1.34 years
Excellent -37 pts over 2 years

In 2018, the repayment capacity of MI MEDICAL INNOVATION (-24.64) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 225.16. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2019) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

225.157

Liquidity indicators evolution
MI MEDICAL INNOVATION

Sector positioning

Liquidity ratio
225.16 2019
2017
2018
2019
Q1: 141.47
Med: 224.29
Q3: 369.63
Good -22 pts over 3 years

In 2019, the liquidity ratio of MI MEDICAL INNOVATION (225.16) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
4.48x 2018
2017
2018
Q1: 0.0x
Med: 0.49x
Q3: 3.63x
Excellent +21 pts over 2 years

In 2018, the interest coverage of MI MEDICAL INNOVATION (4.5x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2019) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2019) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2019) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2019) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
MI MEDICAL INNOVATION

Positioning of MI MEDICAL INNOVATION in its sector

Comparison with sector Fabrication de matériel médico-chirurgical et dentaire

Similar companies (Fabrication de matériel médico-chirurgical et dentaire)

Compare MI MEDICAL INNOVATION with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication de matériel médico-chirurgical et dentaire

Frequently asked questions about MI MEDICAL INNOVATION

What is the revenue of MI MEDICAL INNOVATION ?

The revenue of MI MEDICAL INNOVATION in 2018 is 1.0 M€.

Is MI MEDICAL INNOVATION profitable?

MI MEDICAL INNOVATION recorded a net loss in 2019.

Where is the headquarters of MI MEDICAL INNOVATION ?

The headquarters of MI MEDICAL INNOVATION is located in CHANAC (48230), in the department Lozere.

Where to find the tax return of MI MEDICAL INNOVATION ?

The tax return of MI MEDICAL INNOVATION is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does MI MEDICAL INNOVATION operate?

MI MEDICAL INNOVATION operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.